Novartis shielded from punitive damages in Zometa, Aredia case; Pfizer ad banned in U.K.;

@FiercePharma: Top-read story Tues: Today's need-to-know on the Pfizer-AstraZeneca drama? It's all right here. Article | Follow @FiercePharma

@TracyStaton: Big news that doesn't involve Pfizer or AstraZeneca? Refreshing. First: Forest's new chief, Brent Saunders, will head up Actavis post-buyout. | Follow @TracyStaton

@EricPFierce: Canada orders Biolyse to halt production of injectable drug paclitaxel at a plant in Ontario. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Sanofi steps up meningitis marketing amid lagging Menactra sales. FierceVaccines story | Follow @CarlyHFierce

> A federal judge in North Carolina ruled that punitive damages could not be assessed against Swiss drugmaker Novartis ($NVS) in a case alleging jaw injuries caused by its bone drugs Zometa and Aredia because of a lack of evidence that executives acted improperly. Report (reg. req.)

> U.K. cost watchdog NICE declined to approve Johnson & Johnson's ($JNJ) prostate cancer drug Zytiga for patients who have yet to receive chemotherapy. Story

> While cancer patients in the U.S. may have access to drugs not approved in the U.K., they often are more likely to be bankrupted by paying for them, a former Royal College of General Practitioners said in defending stands taken by NICE. Story

> A generic and three branded drugs from Johnson & Johnson ($JNJ), Forest Laboratories ($FRX) and H. Lundbeck used to treat alcoholism were found to reduce addiction. Story

> India's Dr. Reddy's Laboratories has shuffled top management, saying that it wanted to separate the roles of the chairman, CEO and managing director. Story

> The World Health Organization convened a meeting of experts to assess the international risk posed by the highly infectious and often lethal Middle East Respiratory Syndrome (MERS). Story

Medical Device News

@FierceMedDev: ICYMI yesterday: Medtronic poaches GE exec to lead its $1.5B diabetes biz. Report | Follow @FierceMedDev

@VarunSaxena2: Tonix's sublingual formulation for fibromylagia reaches pivotal trial stage. Story | Follow @VarunSaxena2

@MichaelGFierce: Boston College team makes zinc nano-cages for 'smart' cancer drug delivery. FierceDrugDelivery story | Follow @MichaelGFierce

@EmilyWFierce: 3-D printed prosthesis brings more dexterity to 12-year-old orphan in Haiti. More from MedCityNews | Follow @EmilyWFierce

> St. Jude Medical achieves first U.S. implants of its TAVR system. Story

> Medrobotics captures $26M in Series E cash for robotic surgery device. More

> Guided Therapeutics preps for a third shot at FDA approval for its cervical scanner. Article

Biotech News

@FierceBiotech: AstraZeneca adds an immuno-oncology collaboration for its pipeline star. News | Follow @FierceBiotech

@JohnCFierce: Not naming names, but everybody I talk to in the industry believes Pfizer's $AZN takeover is numbers driven, lousy for research. Everyone. | Follow @JohnCFierce

@DamianFierce: In which we learn that $PFE's Read always carries a coin with "Straight Talk" on one side and "Own It" on the other. Bloomberg story | Follow @DamianFierce

@EmilyMFierce: Naturally occurring molecule could treat Type 2 diabetes. ICYMI from FierceBiotech Research | Follow @EmilyMFierce

> J&J scouts for 50 Bay biotechs with new Janssen incubator. News

> PhIII eye drug failure? Not at all, says an optimistic Gene Signal. Story

> FDA breaks silence on biosimilars with long-awaited proposal. Report

> Isis heralds positive PhII diabetes results from leading antisense drug. Article

Drug Delivery News

> Alnylam's hepatitis B therapy shows promise in animal studies. Article

> Boston College team makes zinc nano-cages for 'smart' cancer drug delivery. Story

> North Carolina State researchers 'smuggle' drugs into cancer cells with ATP. Report

> MIT researchers deliver low doses of siRNA to lung endothelial cells. Story

> Nanoparticles weaken and then kill cancer cells with two-drug timed release. More

Diagnostics News

> AC Immune and Piramal Imaging link in Alzheimer's imaging agent development deal. Report

> Cinven reportedly puts French Dx outfit Sebia up for sale. More

> Counsyl, armed with $28M, begins big rollout of BRCA and other predictive genetic tests. Story

> Abbott commits to companion Dx development for a promising Idera drug. Article

> Smartphone app shows promise monitoring voice patterns to predict biopolar episodes. More

Pharma Marketing News

> Surprise success of Insys' opioid painkiller Subsys raises eyebrows, More

> Big Biotech beats Big Pharma with best-selling 2013 drug launches. News

> Top GSK exec faces life in Chinese prison for alleged 'massive bribery network.' Story

> Fresh off a TV ad launch, Eisai plots another 200-rep add to Belviq sales force. Article

> Teva's years of Copaxone brand-building pay off in new formula's launch. More

> Sanofi looks to make a splash with meningitis booster-shot push. Story

And Finally... The Advertising Standards Authority (ASA) in the U.K. told Johnson & Johnson ($JNJ) it must discontinue using an advertisement that suggested drinking its Benecol yogurt drinks can lower cholesterol. Story